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Abstract Vinculin is found in all adherens junctions, while
metavinculin, a larger splice variant, is coexpressed with vinculin
only in smooth and cardiac muscle. To understand the
significance of metavinculin expression, we compared ligand
binding between turkey vinculin and metavinculin. Residues 1^
258 were found essential for head-tail interactions in both
proteins. The tail domains (VT and MVT, respectively) both bind
to F-actin. However, while VT bundles F-actin, MVT generates
highly viscous F-actin webs. In transfected PtK2 cells, VT causes
F-actin needles or coils, while MVT-expressing cells display a
diffuse F-actin distribution. Thus, the MVT-specific insert
induces an F-actin supraorganization different from the VT-
based form, suggesting that metavinculin has a specific role in
muscle.
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1. Introduction
Vinculin plays a crucial role in linking micro¢laments to the
cytoplasmic face of the plasma membrane in many di¡erent
cell types [1^3], and disruption of the single vinculin gene is
lethal for the development of nematodes [4] as well as for
vertebrates [5]. The 116-kDa protein consists of a large 90-
kDa globular head domain and a rodlike 29-kDa tail domain
that can be separated by endoproteinase GluC (V8) cleavage
[6,7]. Vinculin is a multi-ligand protein which can interact
with talin, K-actinin, paxillin, acidic phospholipids, F-actin
(for review, see [8]) and with the cell contact protein VASP
[9^12]. Interactions between the head and tail domains [13]
can fold the molecule [14] and thus in£uence ligand binding
[15^17] and this head-tail association is regulated by acidic
phospholipids [12,18^20] and possibly phosphorylation [21].
In vertebrate muscle, metavinculin, a larger splice variant, is
coexpressed with vinculin [22^27]. The di¡erence between vin-
culin and metavinculin resides solely in an insert within the
tail domain, which comprises 68 or 69 amino acids in porcine
or chicken smooth muscle, respectively, [26,27] and 79 amino
acids in Xenopus [28]. Except for a small amount detected in
platelets [29], metavinculin has only been found in muscle
tissue. Smooth muscle and cardiac muscle are especially rich
in this vinculin isoform, and some smooth muscle cells, like
those of porcine stomach and blood vessels, express more
metavinculin than vinculin [30]. Immuno£uorescence with
antibodies discriminating between metavinculin and vinculin
revealed that both proteins colocalize in the same adhesion
site, i.e. in the membrane-apposed attachment plaques of
smooth muscle cells, and in costameres and intercalated discs
of cardiocytes [31]. These ¢ndings, together with the overall
structural similarity between metavinculin and vinculin mole-
cules [7,30], have stimulated speculations that these two pro-
teins have a similar, if not identical function in linking actin
¢laments to the plasma membrane [30]. Consistent with this
view, no ligand for the metavinculin-speci¢c insert has been
identi¢ed. On the other hand, de¢ciency in metavinculin is
associated with a particular form of dilated cardiomyopathy
in man [32], suggesting a speci¢c role for this splice variant in
heart muscle.
To characterize intramolecular £exibility and ligand binding
in metavinculin, we mapped the binding sites of the vinculin
and metavinculin tail within the vinculin head. Both tail struc-
tures bind to the same sequence in the vinculin head with
similar a⁄nities. In addition, we compared the F-actin bind-
ing ability of the metavinculin tail (MVT) with that of the
vinculin tail (VT). Using recombinant proteins, we show
that the F-actin binding domain in MVT is functional, but
MVT-actin complexes display an actin ¢lament supraorgani-
zation which di¡ers grossly from that induced by VT, in vitro
and in transiently transfected PtK2 cells.
2. Material and methods
2.1. RT-PCR and expression cloning in E. coli
Total RNA was puri¢ed from turkey gizzard [33] and used for
reverse transcription and polymerase chain reaction (PCR) with the
following primers (see Fig. 1): VT-SE1 (ATATACATATGCTT-
GCTCCTCCAAAA) contains an NdeI-site (italics) with ATG start-
codon and codes for nucleotides 2572^2586 (underlined) of the vincu-
lin coding sequence (GenBank J04126). VT-RE1 (TGGTGCTCGAG-
CTGATACCATGGGGT) contains an XhoI-site (italics) and is com-
plementary to nucleotides 3184^3198 (underlined) of the vinculin
coding sequence. Reverse transcription was carried out with the
RT-PCR Kit (Stratagene). PCR products were cloned in frame with
a C-terminal His-tag into expression vector pET23a (Novagen) to
form pET23-VT and pET23-MVT (vinculin-tail and metavinculin-
tail expression plasmids). Both constructs were sequenced with T7
DNA polymerase.
2.2. Protein expression, puri¢cation and analysis
pET23-VT and pET23-MVT were transformed into E. coli
BL21(DE3). Twelve hours after induction log phase cultures by
IPTG, the cells were harvested and lysed in ice-cold lysis bu¡er (50
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mM Na-phosphate pH 8.0, 0.3 M NaCl, 0.5 mM PMSF, 5 mM 2-
mercaptoethanol) by addition of lysozyme (1 mg/ml) and French press
treatment. Cleared extracts were passed over a column of 1 ml Ni-
NTA resin (Qiagen) and the soluble protein was eluted with a 40-ml
linear gradient (0^0.5 M imidazole) in washing bu¡er (50 mM Na-
phosphate, 0.3 M NaCl, 10% glycerol, 0.5 mM PMSF, 5 mM 2-mer-
captoethanol, pH 6.0). Fractions containing VT or MVT, respectively,
were pooled, dialyzed against bu¡er A (50 mM Tris-HCl, pH 7.2,
20 mM NaCl, 1 mM EGTA, 1 mM EDTA, 5 mM 2-mercaptoetha-
nol) and further puri¢ed by FPLC (Pharmacia, Uppsala, Sweeden) on
a MonoS HR 5/5 cation exchange column in bu¡er A, and a linear
NaCl gradient (0.02^0.5 M). Electrophoretically pure fractions were
pooled and either stored at 4‡C or drop-frozen in liquid nitrogen and
stored at 380‡C. Protein concentrations were either determined ac-
cording to Bradford [34] or by using quantitative amino acid analysis
with pre-column derivatization as described [35]. Approximately
1.5 mg of pure protein was obtained per 2 l culture. Vinculin head
fragment was obtained from puri¢ed gizzard vinculin by V8 cleavage
[36]. Proteins were separated by SDS-PAGE [37]. Gels were stained
with Coomassie Brilliant Blue or transferred onto Immobilon P
(Millipore). Blotting and immunolabeling were performed as de-
scribed [38], using a monoclonal antibody (4E7) speci¢c for an epitope
shared by both VT and MVT, or a histidine-tag antibody (Dianova).
N-terminal sequencing was performed as described [36].
2.3. Probing for head-to-tail interactions
Interaction of VH with VT or MVT tail domains was tested with
the yeast two hybrid system [39], using the Matchmaker Kit (Clontech
Lab., Inc.), according to the manufacturers’ instructions. cDNAs cod-
ing for VH (residues 1^850) and a variety of deletion fragments were
cloned into the EcoRI/SalI site of plasmid pGBT9. Analogously,
cDNAs coding for VT (residues 858^1066), MVT (residues 858^
1139) and a tail deletion clone (residues 993^1043) were ampli¢ed
by PCR and cloned in frame with the activation domain of the tran-
scription factor GAL4 into the EcoRI/SalI site of pGAD424. For
quantitative evaluation, L-galactosidase activity was assayed in solu-
tion with o-nitrophenyl-L-D-galactopyranoside as a substrate, accord-
ing to the manufacturers’ instruction. The signal obtained for VH-VT
interaction was de¢ned as 100%.
2.4. Actin binding assays
Skeletal muscle actin, obtained as described [40] and further puri-
¢ed by an additional gel ¢ltration step, was polymerized in F-bu¡er
(10 mM imidazole, pH 7.4, 1 mM ATP, 0.1 M KCl, 2 mM MgCl2)
and incubated with the recombinant proteins, also in F-bu¡er, at
various concentrations. Complex formation was assessed by air-fuge
sedimentation at 100 000Ug for 45 min as described [38]. Low shear
viscometry was performed with a falling-ball viscometer as described
in [41]. Bundling of TRITC-phalloidin-labeled F-actin by VT or MVT
was monitored microscopically [41].
2.5. Transfection experiments
VT and MVT coding sequences were ampli¢ed from the prokary-
otic expression vectors pET23-VT and pET23-MVT (see above) by
PCR, using Pfu-polymerase (Stratagene) as above, and cloned into
pcDNA-BiP to obtain the eukaryotic expression vectors pcVT-BiP
and pcMVT-BiP. pcDNA-BiP is a modi¢cation of the pcDNA3 vec-
tor (Invitrogene) equipped C-terminally with 10 amino acids of the
birch pollen pro¢lin sequence, speci¢cally recognized by a monoclonal
antibody [42]. PtK2 epithelial cells, grown on glass cover slips in
DMEM supplemented with 10% FCS, were transfected with these
probes as a Ca-phosphate precipitate. Twenty-four hours later, the
medium was changed and the cells were further incubated for 48 h.
They were subsequently ¢xed in 3.7% formaldehyde, extracted in 0.2%
Triton X-100 and immunolabeled with the birch pro¢lin antibody and
a TRITC-labeled second antibody (Sigma) to detect VT and MVT,
respectively. Counterstaining of F-actin and microscopy were as de-
scribed [42].
3. Results
3.1. Puri¢cation and characterization of recombinant VT and
MVT
Turkey vinculin tail (VT, residues 858^1066) and metavin-
culin tail (MVT, residues 858^1135), corresponding to the VT
and MVT fragments as depicted in Fig. 1A and equipped with
a histidine-tag, were expressed in a soluble form. From the
bacterial lysate, they were strongly enriched by a⁄nity chro-
matography on Ni-NTA resin and puri¢ed to homogeneity by
chromatography on MonoS (Fig. 1B). In SDS-PAGE, VT
and MVT displayed an apparent molecular mass of 27 000
Da and 38 000 Da, as compared to the calculated molecular
masses of 24 289 and 31 778 Da. Identity and integrity of both
fragments were therefore controlled by immunoblotting with a
monoclonal antibody (4E7) recognizing VT as well as MVT,
by immunoblotting with an antibody against the histidine-tag
and by N-terminal sequencing and quantitative amino acid
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Fig. 1. A: Schematic drawing of the domain organization of vincu-
lin (V) and metavinculin (MV). The 90-kDa N-terminal head is
common to both molecules. In MV, the tail sequence contains a 69
residues long insert (hatched), C-terminal of the proline rich hinge
(residues 837^878, shaded). V8 (arrows) refers to cleavage sites of
the V8 protease. VT-SE1 and VT-RE1: starting points for PCR am-
pli¢cation of tail structures in both directions. B: Expression and
puri¢cation of recombinant VT (1^4) and MVT (1P^4P). The stained
SDS-PAGE pro¢les show bacterial lysates before (lanes 1,1P) and
after (lanes 2,2P) induction, an aliquot from the pooled fractions ob-
tained after Ni-a⁄nity column (lanes 3,3P) and the product as puri-
¢ed on MonoS (lanes 4,4P). The numbers on the left refer to molec-
ular weight markers.
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analysis (data not shown). By these criteria, both proteins
were found to be of the expected sequence and size, despite
their aberrant position in SDS-PAGE. In dot overlays [20],
VT and MVT interacted with VH as well as with F-actin (data
not shown), demonstrating that both recombinant fragments
were functional and contained intact F-actin binding sites.
3.2. Metavinculin forms intramolecular bonds like vinculin
The interaction of VT and MVT with VH was analyzed in
the yeast two-hybrid system. A series of VH fragments was
constructed as fusion proteins with the GAL4-DNA-binding
domain in pGBT9 and tested for interaction with VT or MVT
constructed as a fusion protein with the GAL4-activation do-
main in pGAD424. A strong interaction of both VT and
MVT was observed with the vinculin head (V1^850; Fig. 2),
con¢rming that the VH-VT interaction is of rather high a⁄n-
ity, with a Kd in the nanomolar range [13], and demonstrating
that for MVT this is not substantially altered. By using dele-
tion mutants, a fragment corresponding to amino acid resi-
dues 1^258 was found su⁄cient and necessary for the inter-
action of VH with VT as well as MVT.
3.3. MVT-F-actin complexes do not sediment
As shown previously, genuine and recombinant VT frag-
ments can be cosedimented with actin ¢laments [38,43]. Sur-
prisingly, and despite MVT binding to F-actin had been seen
in dot overlays, sedimentable MVT-F-actin complexes were
not formed and F-actin did not sediment under conditions
where VT-F-actin pelleted (Fig. 3). This e¡ect could be ti-
trated. At a molar ratio of 0.15:1 (MVT/actin), only approx-
imately 30% of the actin was sedimentable, and above this
value all actin remained in the supernatant (Fig. 3A). The
in£uence of MVT on F-actin was studied in the presence of
either vinculin head (VH) or VT (Fig. 3B). At a constant ratio
of F-actin/MVT (1:0.25) increasing amounts of VH restored
F-actin sedimentation, probably by binding MVT (see Fig. 2)
and thus abolishing its e¡ect on F-actin. In accordance with
this, actin was found in the pellet, while MVT and VH re-
mained in the supernatant. The addition of increasing
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Fig. 3. SDS-PAGE pro¢les of pellets (P) and supernatants (S) ob-
tained in cosedimentation assays. A: Sedimentation assays of mix-
tures of F-actin and MVT. Prepolymerized actin (2 WM) was mixed
with VT or various amounts of MVT, in the molar ratios as indi-
cated. VT sediments with F-actin under these conditions, while
MVT interferes with actin sedimentation. B: Competitive sedimenta-
tion assay of F-actin (2 WM) with MVT (0.5 WM) and either the
vinculin head (VH) or VT. The molar ratios of VH and VT to F-
actin are indicated. Molecular weight markers are given on the left.
The positions of vinculin head (VH), actin (A), MVT and VT are
indicated on the right.
Fig. 4. Viscosity of polymerized actin (A) in the absence (dotted
line) and the presence of MVT (O) or VT (a), as measured by fall-
ing ball viscometry. The viscosity of the control F-actin solution
was normalized to 1, and all data were plotted in relation to this
standard (normalized viscosities, ordinate). Abscissa: molar ratios of
MVT and VT to 2 WM F-actin.
Fig. 2. Two-hybrid mapping of the VT or MVT binding site within
the vinculin head. Binding of VT (black columns) and MVT
(hatched columns) to various vinculin head fragments was measured
in terms of L-galactosidase activity. The interaction of the full
length vinculin head (V1^850) and tail (V858^1066) domains was
de¢ned as 100%. Numbers in the abscissa indicate vinculin residues
in sequences expressed as fusion proteins with the GAL4-DNA-
binding domain. pTD1 and pVA3: positive control sequences sup-
plied by the manufacturer (see Section 2). Note that V1^258 is nec-
essary and su⁄cient for binding.
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amounts of VT to the same constant mixture of F-actin/MVT
(1:0.25) also decreased the e¡ect of MVT on F-actin sedimen-
tation. In this case, VT cosedimented with F-actin, as ex-
pected, while MVT remained mostly in the supernatant, sug-
gesting that the a⁄nity of VT for F-actin is higher than that
of MVT (Fig. 3B).
These results suggested that MVT might change the supra-
structure of F-actin into an arrangement not sedimentable
under the conditions chosen (100 000Ug). This hypothesis
was tested by viscometry and light microscopy.
3.4. Metavinculin and vinculin tails have di¡erential e¡ects on
F-actin viscosity
Viscometric assays were performed under low shear condi-
tions, as described in [20,41]. At low molar ratios (up to
approximately 0.3:1), VT as well as MVT strongly increased
the low shear viscosity of F-actin (Fig. 4), as already reported
for VT [15]. This suggests that both fragments crosslink or
gelate F-actin, albeit to a di¡erent extent (Fig. 4). However, at
higher molar ratios, the e¡ects of VT and MVT on F-actin
di¡ered drastically. While MVT/actin mixtures displayed an
almost constant high viscosity (Fig. 4), VT at higher concen-
trations caused a drastic reduction in F-actin viscosity, which
fell below the level of the F-actin control (Fig. 4). The addi-
tion of VH or VT was able to reduce the MVT-induced high
viscosity level to values of the control F-actin solution or even
below (Table 1). Together with the sedimentation data (Fig.
3), these results indicate that MVT strongly gelates F-actin,
but as MVT in solution has a higher a⁄nity to VH and VT
competes for the same binding site on F-actin, this e¡ect can
be titrated by the addition of these components. On the other
hand, VT, at high concentrations, organizes F-actin into a
structure of low viscosity.
3.5. MVT induces actin ¢lament webs, while VT bundles actin
¢laments
Using light microscopy with £uorescently labeled F-actin
[41], we could visualize the di¡erent forms of actin supraorga-
nization induced by either MVT or VT. At a molar ratio of
0.6:1 (MVT or VT/actin), the di¡erence in viscosity between
both probes was almost maximal (Fig. 4). Aliquots of these
mixtures and F-actin alone were applied to a glass coverslip
and examined by £uorescence microscopy (Fig. 5). While con-
trol actin ¢laments were rather homogeneously distributed,
displaying some coarser ¢bers which might be parallel aggre-
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Fig. 5. Fluorescence microscopic analysis of TRITC-labeled F-actin (control), and F-actin/MVT and F-actin/VT mixtures (both at a molar
MVT or VT to actin ratio of 0.6:1). While the control contains a network of rather coarse ¢lamentous structures (a), MVT/actin mixtures re-
veal a much ¢ner texture (b), and VT/actin mixtures show prominent bundles and needle-like aggregates (c). Bar = 10 Wm.
Fig. 6. Fluorescence micrographs of PtK2 cells transfected with
MVT (a,aP) or VT (b,bP) constructs. The cells were stained with an
antibody against the BiP-tag (a,b; see text) and counterstained for
F-actin with FITC-phalloidin (aP,bP). While MVT caused F-actin to
arrange in a dense web (a,aP), VT collected F-actin into large bun-
dles or coils many of which were deposited in the perinuclear area
(insets, b,bP). Bar = 20 Wm.
Table 1
Relative viscosity of di¡erent combinations of VH, VT and MVT
with actin
Component (2 WM) Additions Molar ratioa Relative viscosityb
G-actin None ^ 1.0
MVT None ^ 1.1
VT None ^ 1.1
VH None ^ 1.1
F-actin None ^ 5.0
F-actin MVT 1:0.45 23.5
F-actin MVT+VH 1:0.45:0.2 5.5
F-actin MVT+VT 1:0.45:0.2 7.0
F-actin MVT+VT 1:0.45:0.9 3.0
aActin/MVT/VH (or VT, respectively).
bThe relative viscosity values were normalized to that of 2 WM G-
actin = 1.0.
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gates (Fig. 5a), samples containing MVT revealed a much
¢ner network or web (Fig. 5b). On the other hand, samples
containing VT showed actin ¢laments collected into promi-
nent bundles or needles, interspersed with areas almost devoid
of ¢laments (Fig. 5c), as already described [41]. These results
support the interpretation of the results shown in Figs. 3 and
4: high amounts of MVT cause the rearrangement of actin
¢laments into viscous webs which are di⁄cult to sediment,
while VT can recruit actin ¢laments into large needle-like
structures which sediment easily but show a low viscosity, in
analogy to the e¡ect expected for a phase separation [41].
3.6. In transfected cells, MVT and VT show di¡erential e¡ects
on actin organization
PtK2 cells were transfected with MVT or VT containing
constructs, and the expressed MVT and VT proteins were
monitored in total protein extracts in immunoblots (data
not shown) and by immuno£uorescence (Fig. 6). When the
transfected cells were examined more closely, a drastic di¡er-
ence in the arrangement of F-actin between MVT- and VT-
expressing cells became evident: in the MVT-expressing cells,
actin ¢laments were arranged in a dense web, which also
contained MVT and ¢lled a large part of the cytoplasm
(Fig. 6a,aP). In contrast, VT-expressing cells displayed densely
packed aggregates of F-actin costaining for VT (Fig. 6b,bP).
In many cases, these aggregates were deposited as tightly
coiled bundles in the perinuclear area (Fig. 6b,bP, insets).
Hence, in transiently transfected cells, the expressed MVT
and VT fragments interact with ¢lamentous actin, exerting
the same pronounced, but distinct e¡ects on actin organiza-
tion as in vitro.
4. Discussion
In this study, we show that metavinculin, a splice variant of
vinculin, binds to F-actin via an actin binding domain local-
ized in the C-terminal tail, analogous to vinculin. Since the
actin binding motif in avian vinculin has been assigned to
sequences C-terminal of residue 893 [20,38], while the 69 res-
idue long metavinculin-speci¢c insert is located between resi-
dues 915 and 916, a disruption of the actin-binding site by the
insertion of this rather acidic sequence stretch (pI 3.65, as
calculated by the program Isoelectric from the GCG package)
and failure of actin binding might have been expected. How-
ever, cosedimentation studies and viscosity assays clearly dem-
onstrate a direct interaction between MVT and F-actin. Thus,
the metavinculin insert does not physically interrupt the actin-
binding region.
In analogy to vinculin, we found that while the isolated
metavinculin tail (MVT) binds well to F-actin, the intact
metavinculin, as isolated from gizzard, binds only weakly or
not at all (data not shown). These data suggested that the
biological activity of metavinculin is regulated by an intra-
molecular interaction between the head and tail domain, as
had been described earlier for vinculin [13,17,19,36]. Using the
yeast two hybrid system, we now mapped the vinculin and
metavinculin tail binding site to the N-terminal third (residues
1^258) of the head domain, con¢rming earlier results obtained
with GST-fusion proteins for vinculin [44]. No signi¢cant dif-
ferences in the a⁄nity of VT or MVT for VH were detected.
Thus, the head might cover the F-actin binding site within the
tail domains of both isoforms, and the tail domains might
interfere with the binding sites of K-actinin and talin, which
have been mapped to the same region of the head domain
[36,45], and even with the binding of VASP to the proline-
rich hinge region [9,10]. As the head-tail interactions in both
cases are of high a⁄nity, for myo¢brillar anchoring, metavin-
culin in muscle would have to be opened and activated, pos-
sibly by oligomerization and phospholipid binding, as recently
postulated for vinculin [12,18,20].
Sedimentation and viscosity assays demonstrated that MVT
has a strong gelating e¡ect on actin ¢laments, and these data
were corroborated by direct microscopic inspection of MVT/
F-actin mixtures, which displayed a ¢ne texture of interwoven
¢laments, distinct from the image obtained for the F-actin
control, and strikingly di¡erent from the F-actin bundles in-
duced by VT. The data obtained with transiently transfected
PtK2 cells are consistent with the in vitro e¡ects. At present,
we can only speculate why the insertion of the MVT-speci¢c
sequence into the tail counteracts this bundling activity and
causes the formation of F-actin webs instead. It is conceivable
that the addition of negative charges plus an increase in tail
length yields a structure which has an overall lower a⁄nity to
F-actin, but is more £exible. Such a molecule might then be
capable to bind at crossover points of actin ¢laments, prevent-
ing parallel arrangements but stabilizing a network instead.
Our results suggest that the ratio between vinculin and
metavinculin at the cytoplasmic face of attachment plaques
might in£uence the actin organization in this area. In the
cell-matrix junctions of non-muscle cells, the terminal portions
of actin ¢laments, confronted with high local concentrations
of activated vinculin, would be bundled into the arrowhead-
shaped focal adhesions. In the intercalated discs and attach-
ment plaques of heart and smooth muscle, respectively, which
both contain vinculin and metavinculin [31], the thin ¢laments
do not converge but are anchored to the plasma membrane
either in parallel or obliquely in a criss-cross pattern [46].
Based on the data presented here, it is conceivable that the
ratio between both isoforms might determine the micro¢la-
ment suprastructure. Alternatively, the muscle-speci¢c expres-
sion of metavinculin might be correlated with the fact that
attachment plaques and intercalated discs, once assembled,
are permanent structures, in contrast to the highly dynamic
focal contacts of non-muscle cells. Another possibility has
recently been proposed by Ehler et al. [47]. These authors
report on several smooth muscle-speci¢c features in a myo¢-
broblastic cell line (IMR-90), including the expression of
metavinculin. They suggest that metavinculin might mediate
the regular spacing and longitudinal arrangement of actin
attachment sites seen in these cells. Further investigations
are needed to discriminate between these di¡erent possibilites.
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